OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) - Q4 2012 holdings

$3.48 Billion is the total value of OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC)'s 20 reported holdings in Q4 2012. The portfolio turnover from Q3 2012 to Q4 2012 was 900.0% .

 Value Shares↓ Weighting
CVH BuyCOVENTRY$94,170,000,000
+196.0%
2,100,601
+175.3%
31.80%
-50.0%
NXY NewNEXEN IN$70,517,000,0002,617,567
+100.0%
23.81%
S NewSPRINT N$57,612,000,00010,160,780
+100.0%
19.46%
PXP NewPLAINS E$29,028,000,000618,400
+100.0%
9.80%
SHS NewSAUER-DA$12,721,000,000238,356
+100.0%
4.30%
MMR NewMCMORAN$11,153,000,000694,913
+100.0%
3.77%
NewCLEARWIRcla$9,229,000,0003,193,637
+100.0%
3.12%
CLWR NewCLEARWIRcla$9,229,000,0003,193,637
+100.0%
3.12%
NYX NewNYSE EUR$1,763,000,00055,908
+100.0%
0.60%
NXY NewNEXEN INcall$693,000,000439,300
+100.0%
0.23%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR/A filed 2013-06-26
  • View 13F-HR/A filed 2013-08-13
  • View 13F-HR/A filed 2013-11-14
  • View 13F-HR/A filed 2014-02-13
Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
META PLATF36Q3 20232.3%
SPDR S&P 533Q3 20230.7%
ACTIVISION29Q3 202371.3%
AMAZON COM29Q3 20230.8%
GAMING & L29Q3 20230.8%
SPDR S&P29Q1 20230.1%
DISNEY W28Q3 20212.0%
POST HLD27Q2 20201.8%
GENERAL27Q3 20221.4%
CAMDEN PPT27Q3 20230.6%

View OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC)'s complete holdings history.

Latest significant ownerships (13-D/G)
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) Q4 2012 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
HERON THERAPEUTICS, INC. /DE/Sold outFebruary 13, 202300.0%
MAGELLAN HEALTH INCSold outFebruary 13, 202300.0%
New Providence Acquisition Corp. IIFebruary 13, 20232,227,5008.9%
Nuance Communications, Inc.Sold outFebruary 13, 202300.0%
SCP & CO Healthcare Acquisition CoSold outFebruary 13, 202300.0%
ACORDA THERAPEUTICS INCSold outFebruary 14, 202200.0%
Amryt Pharma plcFebruary 14, 20229,950,0003.1%
Evolv Technologies Holdings, Inc.February 14, 20221,547,3111.1%
GreenSky, Inc.February 14, 2022698,5530.8%
GTY Technology Holdings Inc.February 14, 2022758,0001.3%

View OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC)'s complete significant-ownership history.

Latest filings
TypeFiled
13F-HR/A2024-05-15
13F-HR/A2024-05-15
13F-HR/A2024-05-15
13F-HR/A2024-05-15
13F-HR2024-05-15
13F-HR/A2024-02-14
13F-HR/A2024-02-14
13F-HR/A2024-02-14
13F-HR/A2024-02-14
13F-HR2024-02-14

View OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC)'s complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported total value is incorrect (3480523000.0 != 296115000000.0)
  • The reported has been restated
  • The reported has been amended

Export OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC)'s holdings